Asceneuron Company

Asceneuron is a biotech company that specializes in small molecule drug discovery for neurodegenerative diseases, particularly orphan tauopathies and Alzheimer's disease. Tauopathies are neurodegenerative diseases that currently have no treatment and rapidly progress to debilitating conditions. Asceneuron aims to become a leading company in this field by focusing on areas of high unmet medical need. Alzheimer's disease is a major healthcare problem due to increasing life expectancy, and current treatment options provide limited benefits, highlighting the need for more effective and better-tolerated medicines that address symptomatic relief and disease progression.


Headquarters: Lausanne
Employee Number: 1-10
Industry: BioTech
Technology: Precision medicine
Founded Date: 2012